Author

Steven A. Buck

Children's Hospital of MichiganORCID 0000-0001-5015-0187Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Abhinav DeoliD· 1 shared Amro AboukameeliD· 1 shared Asfar Sohail AzmiiD· 1 shared Francis BurrowsiD· 1 shared Jaroslaw Pawel MaciejewskiiD· 1 shared Jay YangiD· 1 shared Jeff Justin AguilariD· 1 shared Jevon A. CutleriD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abhinav DeolORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintMar 13, 2026

Combined Menin and XPO1 inhibition drive synergistic antileukemic activity in KMT2Ar and NPM1-m AML

Md. Hafiz Uddin, Sandhya Dhiman, Yufen Han…·Suresh Kumar Balasubramanian

This study shows that combining Menin and XPO1 inhibitors synergistically inhibits KMT2A-r and NPM1-m AML cell growth and improves survival in xenograft models.

DOI 10.64898/2026.03.10.710924

humanbulk RNA-seq

𝕏 PostBluesky